Literature DB >> 118812

Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections.

H Wulff, K M Johnson.   

Abstract

Immunoglobulin M antibodies can be measured by indirect immunofluorescence in sera of patients suffering from Lassa fever or Marburg virus disease 4-7 days after onset of illness. Titres reach a peak 1-2 weeks later. These antibodies disappear, or titres decrease considerably, 1-2 months after onset of illness. Antiviral IgG antibodies can be detected at the same time as, or a little later than, IgM antibodies, but they persist much longer. None of the three patients discussed in this paper who died of Lassa fever developed IgG antibodies and only one developed IgM antibodies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 118812      PMCID: PMC2395825     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-IgM.

Authors:  P V Shirodaria; K B Fraser; F Stanford
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

2.  Measurement of antibodies to Machupo virus by the indirect fluorescent technique.

Authors:  C J Peters; P A Webb; K M Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1973-02

3.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

4.  Epidemiology of Machupo virus infection. 3. Significance of virological observations in man and animals.

Authors:  K M Johnson
Journal:  Am J Trop Med Hyg       Date:  1965-09       Impact factor: 2.345

5.  Indirect immunofluorescence for the diagnosis of Lassa fever infection.

Authors:  H Wulff; J V Lange
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

6.  Early detection of antigen and estimation of virus yield in specimens from patients with Marburg virus disease.

Authors:  H Wulff; W Slenczka; J H Gear
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

7.  Outbreake of Marburg virus disease in Johannesburg.

Authors:  J S Gear; G A Cassel; A J Gear; B Trappler; L Clausen; A M Meyers; M C Kew; T H Bothwell; R Sher; G B Miller; J Schneider; H J Koornhof; E D Gomperts; M Isaäcson; J H Gear
Journal:  Br Med J       Date:  1975-11-29

8.  Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay.

Authors:  V Knez; J A Stewart; D W Ziegler
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

  8 in total
  29 in total

1.  Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation.

Authors:  D G Bausch; P E Rollin; A H Demby; M Coulibaly; J Kanu; A S Conteh; K D Wagoner; L K McMullan; M D Bowen; C J Peters; T G Ksiazek
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 2.  Laboratory Diagnosis of Lassa Fever.

Authors:  Vanessa Raabe; Jeffrey Koehler
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

3.  Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy.

Authors:  M Valassina; M G Cusi; P E Valensin
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.

Authors:  David Safronetz; James E Strong; Friederike Feldmann; Elaine Haddock; Nafomon Sogoba; Douglas Brining; Thomas W Geisbert; Dana P Scott; Heinz Feldmann
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

5.  Electron microscopy and antigenic studies of uncharacterized viruses. I. Evidence suggesting the placement of viruses in families Arenaviridae, Paramyxoviridae, or Poxviridae.

Authors:  H G Zeller; N Karabatsos; C H Calisher; J P Digoutte; F A Murphy; R E Shope
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Preparation and use of erythrocyte-globulin conjugates to Lassa virus in reversed passive hemagglutination and inhibition.

Authors:  R A Goldwasser; L H Elliott; K M Johnson
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

7.  A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

Authors:  Anita K McElroy; Rama S Akondy; Jessica R Harmon; Ali H Ellebedy; Deborah Cannon; John D Klena; John Sidney; Alessandro Sette; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

8.  Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay.

Authors:  B S Niklasson; P B Jahrling; C J Peters
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

9.  Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain.

Authors:  P B Jahrling; C J Peters
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

10.  Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.

Authors:  Megan M Illick; Luis M Branco; Joseph N Fair; Kerry A Illick; Alex Matschiner; Randal Schoepp; Robert F Garry; Mary C Guttieri
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.